Prevention of Rh-haemolytic disease.
D000017:ABO Blood-Group System; D000818:Animals; D004899:Erythroblastosis, Fetal / Q000276:immunology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007313:Insecta; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology*; D005719:gamma-Globulins / Q000627:therapeutic use
D000017:ABO Blood-Group System; D005719:gamma-Globulins